Company
OneBiosciences
Delivering single-cell precision to the clinic.
Also known as One Biosciences
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Founded
- 2020
- Customers
- clinicians and pharma partners
- Legal name
- One Biosciences
Record updated 20 September 2026
About
Cellular heterogeneity drives disease complexity. We deliver AI-powered, clinical-grade single-cell profiling to accelerate therapeutic development and transform patient care across disease areas.
Funding snapshot
- Latest round
- Grant2026-09-10
Funding rounds
- Grant
- 2026-09-10
- Series A
- 2025-07-17
Products
- Other
- OneMap